seed
Stage
1
Investors
About
BioOrbit is a space manufacturing company developing hardware for the large-scale crystallization of protein drugs. Using microgravity conditions in low-Earth orbit, BioOrbit aims to transform protein-based drugs into highly ordered crystalline forms, enabling the reformulation of intravenous therapies into self-administrable subcutaneous treatments.
Explore BioOrbit's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.